Antibe Therapeutics Stock Analysis
| ATBPF Stock | USD 0.22 0.00 0.00% |
Antibe Therapeutics is overvalued with Real Value of 0.18 and Hype Value of 0.22. The main objective of Antibe Therapeutics pink sheet analysis is to determine its intrinsic value, which is an estimate of what Antibe Therapeutics is worth, separate from its market price. There are two main types of Antibe Therapeutics' stock analysis: fundamental analysis and technical analysis.
The Antibe Therapeutics pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Antibe Therapeutics' ongoing operational relationships across important fundamental and technical indicators.
Antibe |
Antibe Pink Sheet Analysis Notes
The company has price-to-book (P/B) ratio of 0.61. Some equities with similar Price to Book (P/B) outperform the market in the long run. Antibe Therapeutics recorded a loss per share of 0.41. The entity last dividend was issued on the 1st of December 2020. The firm had 1:10 split on the 1st of December 2020. Antibe Therapeutics Inc., a biotechnology company, engages in developing novel therapeutics and medical devices in the areas of pain, inflammation and regenerative medicine in Canada, Europe, the United States, and internationally. Antibe Therapeutics Inc. was incorporated in 2009 and is headquartered in Toronto, Canada. Antibe Therapeutics is traded on OTC Exchange in the United States.The quote for Antibe Therapeutics is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Antibe Therapeutics please contact LLB JD at 416 922 3460 or go to https://www.antibethera.com.Antibe Therapeutics Investment Alerts
| Antibe Therapeutics generated a negative expected return over the last 90 days | |
| Antibe Therapeutics has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (25.06 M) with profit before overhead, payroll, taxes, and interest of 3.55 M. | |
| Antibe Therapeutics has accumulated about 50.19 M in cash with (16.92 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.96, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Antibe Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 22.59 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Antibe Therapeutics's market, we take the total number of its shares issued and multiply it by Antibe Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
Antibe Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Antibe Therapeutics Price Movement Analysis
The output start index for this execution was four with a total number of output elements of fifty-seven. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Antibe Therapeutics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Antibe Therapeutics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
About Antibe Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Antibe Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Antibe shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Antibe Therapeutics. By using and applying Antibe Pink Sheet analysis, traders can create a robust methodology for identifying Antibe entry and exit points for their positions.
Antibe Therapeutics Inc., a biotechnology company, engages in developing novel therapeutics and medical devices in the areas of pain, inflammation and regenerative medicine in Canada, Europe, the United States, and internationally. Antibe Therapeutics Inc. was incorporated in 2009 and is headquartered in Toronto, Canada. Antibe Therapeutics is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Antibe Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Complementary Tools for Antibe Pink Sheet analysis
When running Antibe Therapeutics' price analysis, check to measure Antibe Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Antibe Therapeutics is operating at the current time. Most of Antibe Therapeutics' value examination focuses on studying past and present price action to predict the probability of Antibe Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Antibe Therapeutics' price. Additionally, you may evaluate how the addition of Antibe Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |